首页 | 本学科首页   官方微博 | 高级检索  
   检索      


A novel strategy for evasion of NK cell immunity by tumours expressing core2 O-glycans
Authors:Tsuboi Shigeru  Sutoh Mihoko  Hatakeyama Shingo  Hiraoka Nobuyoshi  Habuchi Tomonori  Horikawa Yohei  Hashimoto Yasuhiro  Yoneyama Takahiro  Mori Kazuyuki  Koie Takuya  Nakamura Toshiya  Saitoh Hisao  Yamaya Kanemitsu  Funyu Tomihisa  Fukuda Minoru  Ohyama Chikara
Institution:Department of Biochemistry, Oyokyo Kidney Research Institute, Hirosaki, Japan. tsuboi@oyokyo.jp
Abstract:The O-glycan branching enzyme, core2 β-1,6-N-acetylglucosaminyltransferase (C2GnT), forms O-glycans containing an N-acetylglucosamine branch connected to N-acetylgalactosamine (core2 O-glycans) on cell-surface glycoproteins. Here, we report that upregulation of C2GnT is closely correlated with progression of bladder tumours and that C2GnT-expressing bladder tumours use a novel strategy to increase their metastatic potential. Our results showed that C2GnT-expressing bladder tumour cells are highly metastatic due to their high ability to evade NK cell immunity and revealed the molecular mechanism of the immune evasion by C2GnT expression. Engagement of an NK-activating receptor, NKG2D, by its tumour-associated ligand, Major histocompatibility complex class I-related chain A (MICA), is critical to tumour rejection by NK cells. In C2GnT-expressing bladder tumour cells, poly-N-acetyllactosamine was present on core2 O-glycans on MICA, and galectin-3 bound the NKG2D-binding site of MICA through this poly-N-acetyllactosamine. Galectin-3 reduced the affinity of MICA for NKG2D, thereby severely impairing NK cell activation and silencing the NK cells. This new mode of NK cell silencing promotes immune evasion of C2GnT-expressing bladder tumour cells, resulting in tumour metastasis.
Keywords:core2 O‐glycans  MICA  NK cell immunity  NKG2D  tumour metastasis
本文献已被 PubMed 等数据库收录!
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号